Hologic Selenia With CAD Approval Expected By Year End; Stock Up 17%
This article was originally published in The Gray Sheet
Executive Summary
Hologic's strategy of pursuing co-development and distribution deals for its digital mammography system, combined with its shift to direct sales, appears to be striking a favorable chord with Wall Street onlookers